You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Samarium sm-153 lexidronam pentasodium - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for samarium sm-153 lexidronam pentasodium and what is the scope of freedom to operate?

Samarium sm-153 lexidronam pentasodium is the generic ingredient in one branded drug marketed by Lantheus Medical and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for samarium sm-153 lexidronam pentasodium

US Patents:	0
Tradenames:	1
Applicants:	1
NDAs:	1
Clinical Trials:	6
Formulation / Manufacturing:	see details
DailyMed Link:	samarium sm-153 lexidronam pentasodium at DailyMed

Recent Clinical Trials for samarium sm-153 lexidronam pentasodium

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Cancer Institute (NCI)	Phase 3
Radiation Therapy Oncology Group	Phase 3
NRG Oncology	Phase 3

See all samarium sm-153 lexidronam pentasodium clinical trials

US Patents and Regulatory Information for samarium sm-153 lexidronam pentasodium

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lantheus Medical	QUADRAMET	samarium sm-153 lexidronam pentasodium	INJECTABLE;INJECTION	020570-001	Mar 28, 1997		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for samarium sm-153 lexidronam pentasodium

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lantheus Medical	QUADRAMET	samarium sm-153 lexidronam pentasodium	INJECTABLE;INJECTION	020570-001	Mar 28, 1997	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.